latest wilsonhtm report, page-4

Thanks Ronnie,
Thanks for your imput
I do happen to know a little about this company and some of the people associated with it
What Im trying to evaluate is the risk reward scenario associated with the outcome of the March 22 meeting
I respect your valuation of $1.50+, as you have a good knowledge of the product, but does anyone else besides wilson htm cover this stock and give a valuation?
I also agree that the the odds of approval are good, but what do I stand to lose if they are knocked back? In other words if they go to $1.50 on approval but go back to say $0.55 on rejection, then this to me is a very attractive risk to take. Its this range of risk Im trying to get a handle on